Table 2.

Background immunosuppressive drug regimens

	FX	NFX	NPTHU	P-value
Recipients, n	26	25	42
Tac + MMF + mPSL	16 (62%)	13 (52%)*	35 (84%)	0.02
Tac + MMF	0	1 (4%)	2 (5%)	0.54
Tac + Mz + mPSL	4 (15%)	4 (16%)	1 (2%)	0.10
CyA + MMF + mPSL	4 (15%)	5 (20%)	1 (5%)	0.14
CyA + MMF	1 (4%)	1 (4%)	1 (2%)	0.91
CyA + Mz + mPSL	1 (4%)	1 (4%)	0	0.43
CyA + Mz	0	0	1 (2%)	0.56

Notes: Values are shown as n (%).

^*P<0.05 versus NPTHU.

Abbreviations: FX, febuxostat group; NFX, non-febuxostat group; NPTHU, non-post-transplant hyperuricemia; Tac, tacrolimus; MMF, mycophenolate mofetil; mPSL, methylprednisolone; CyA, cyclosporine; Mz, mizoribine.